Bose, Smriti
Papathanasiou, Athanasios
Karkhanis, Sameep
Appleton, Jason P.
King, Dominic
Batra, Ruchika
Mollan, Susan P.
Jacob, Saiju http://orcid.org/0000-0003-0037-454X
Article History
Received: 9 February 2023
Revised: 18 July 2023
Accepted: 19 July 2023
First Online: 22 August 2023
Declarations
:
: Prof Jacob has served as an international advisory board member for Alexion, Alnylam, ArgenX, Immunovant, Janssen, Regeneron and UCB pharmaceuticals, is currently an expert panel member of Myasthenia Gravis consortium for Argenx pharmaceuticals, and has received speaker fees from Terumo BCT and Eisai pharmaceuticals. None of these are relevant to the submitted manuscript. Prof. Mollan reports advisory board membership for Invex Therapeutics and Janssen. She is currently a consultant for Neurodiem and has received speaker fees from Heidelberg Engineering, and Chugai-Roche Ltd. All outside the submitted work. Dr Appleton is supported in part by a National Institute of Health Research (NIHR) Health and Care Research Scholarship.